It still hasn't informed us of why analyst consensus is at 5 cents per share - and why the broker who sponsored the IPO has a sell on it...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025